Application no. and date | 17731149.5 (espacenet) (Federated) (European Patent Register), 20170620 | Patent/reg. no. and date | DK/EP 3475282, 20230809 | Publication date | 20190501 | Priority no. and date | EP 16175924, 20160623 | EP pub. no. and date |
EP 3475282 20190501 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | | Inventor | GUBA, Wolfgang, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, MARTIN, Rainer E., c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, GRETHER, Uwe, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, GOBBI, Luca, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, KRETZ, Julian, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, IJZERMAN, Adriaan Pieter, c/o Leiden University Rapenburg 70
2311 EZ Leiden, NL, WESTPHAL, Matthias Valentin, c/o Eidgenoessische Technische Hochschule Zuerich Raemistrasse 101
8092 Zuerich, CH | Representative | | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 11/00 (2006.01) , A61P 25/00 (2006.01) , A61P 29/00 (2006.01) , A61P 33/00 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | Title | [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR | Int. application no. | EP2017064994 | Int. publication no. | WO2017220517 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|